|
The US drug regulator conducted a pre-approval inspection (PAI) at the group's manufacturing facility at SEZ-2 located at Pharmez, Ahmedabad from 2 July 2023 to 7 July 2023. The inspection was closed with zero observations.
Zydus Lifesciences is a discovery-driven, global lifesciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies.
The company's consolidated net profit (from continuing operations) tumbled 27.55% to Rs 298.8 crore despite of 31.66% jump in total revenue from operations to Rs 5,010.6 crore in Q4 FY23 over Q4 FY22.
The scrip closed 0.66% lower at Rs 583.30 on Friday, 7 July 2023.
|